Cures 2.0 Discussion Draft
The National Health Council (NHC) is pleased to respond to the discussion draft of 21st Century Cures 2.0 legislation. Created by and for patient organizations 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, sustainable health care. Made up of more than 140 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses representing biopharmaceutical, device, diagnostic, generic drug, and payer organizations.
The NHC greatly appreciated your leadership and partnership on the 21st Century Cures Act and its lasting impact on bringing new treatments and therapies to fruition and shares your desire to “improve how those new treatments and therapies are delivered to patients” through Cures 2.0. This important proposal will build on the tremendous successes of the 21st Century Cures Act, help us prepare for future pandemics and other health disruptions, and lead to the development of and access to new drugs, devices, and other interventions. We are grateful for your continued leadership on these crucial issues.
The following is a title-by-title response to the discussion draft.
Read More
Cures 2.0 Discussion Draft
08/26/2021
The National Health Council (NHC) is pleased to respond to the discussion draft of 21st Century Cures 2.0 legislation. Created by and for patient organizations 100 years ago, the NHC brings diverse organizations together to forge consensus and drive patient-centered health policy. We promote increased access to affordable, high-value, sustainable health care. Made up of more than 140 national health-related organizations and businesses, the NHC’s core membership includes the nation’s leading patient organizations. Other members include health-related associations and nonprofit organizations including the provider, research, and family caregiver communities; and businesses representing biopharmaceutical, device, diagnostic, generic drug, and payer organizations.
The NHC greatly appreciated your leadership and partnership on the 21st Century Cures Act and its lasting impact on bringing new treatments and therapies to fruition and shares your desire to “improve how those new treatments and therapies are delivered to patients” through Cures 2.0. This important proposal will build on the tremendous successes of the 21st Century Cures Act, help us prepare for future pandemics and other health disruptions, and lead to the development of and access to new drugs, devices, and other interventions. We are grateful for your continued leadership on these crucial issues.
The following is a title-by-title response to the discussion draft.
Read More